/
ETBI
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
75% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $132.0K | $0 | $157.4K | $136.1K | $99.7K |
| Cost of revenue | $0 | $0 | $0 | $19.2K | $0 | $160.4K | $205.0K | $209.8K |
| Gross profit | $0 | $0 | $0 | $112.8K | $0 | −$3.0K | −$68.9K | −$110.1K |
| Gross margin | — | — | — | 85.5% | — | -1.9% | -50.6% | -110.4% |
| R&D | $105.4K | $132.1K | $840.2K | $1.1M | $501.8K | $258.3K | $23.7K | $8.9K |
| Operating income | −$605.8K | −$1.7M | −$4.8M | −$4.2M | −$2.6M | −$3.4M | −$1.3M | −$3.3M |
| EBITDA | −$605.8K | −$1.6M | −$4.8M | −$4.1M | −$2.6M | −$3.3M | −$1.2M | −$3.1M |
| Net income | −$622.8K | −$1.7M | −$4.9M | −$4.3M | −$3.0M | −$3.7M | −$1.5M | −$3.5M |
| Net margin | — | — | — | -3242.8% | — | -2363.4% | -1100.3% | -3553.7% |
| EPS (diluted) | -0.03 | -0.05 | -0.10 | -0.02 | -0.01 | 0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
EASTGATE BIOTECH CORP
EASTGATE BIOTECH CORP
Held by traders on TradeandTell
No one on the platform currently holds ETBI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ETBI as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ETBI yet.